Literature DB >> 9275217

Iron accumulation in Alzheimer disease is a source of redox-generated free radicals.

M A Smith1, P L Harris, L M Sayre, G Perry.   

Abstract

Damage from free radicals has been demonstrated in susceptible neuronal populations in cases of Alzheimer disease. In this study, we investigated whether iron, a potent source of the highly reactive hydroxyl radical that is generated by the Fenton reaction with H2O2, might contribute to the source of radicals in Alzheimer disease. We found, using a modified histochemical technique that relies on the formation of mixed valence iron complexes, that redox-active iron is associated with the senile plaques and neurofibrillary tangles-the pathological hallmark lesions of this disease. This lesion-associated iron is able to participate in in situ oxidation and readily catalyzes an H2O2-dependent oxidation. Furthermore, removal of iron was completely effected using deferoxamine, after which iron could be rebound to the lesions. Characterization of the iron-binding site suggests that binding is dependent on available histidine residues and on protein conformation. Taken together, these findings indicate that iron accumulation could be an important contributor toward the oxidative damage of Alzheimer disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9275217      PMCID: PMC23283          DOI: 10.1073/pnas.94.18.9866

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  A specific stain for the detection of nonheme iron proteins in polyacrylamide gels.

Authors:  L M Leong; B H Tan; K K Ho
Journal:  Anal Biochem       Date:  1992-12       Impact factor: 3.365

2.  Immunohistochemical evidence of oxidative [corrected] stress in Alzheimer's disease.

Authors:  M A Pappolla; R A Omar; K S Kim; N K Robakis
Journal:  Am J Pathol       Date:  1992-03       Impact factor: 4.307

3.  Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease.

Authors:  J R Connor; B S Snyder; J L Beard; R E Fine; E J Mufson
Journal:  J Neurosci Res       Date:  1992-02       Impact factor: 4.164

4.  Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.

Authors:  C D Smith; J M Carney; P E Starke-Reed; C N Oliver; E R Stadtman; R A Floyd; W R Markesbery
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

5.  Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study.

Authors:  P F Good; D P Perl; L M Bierer; J Schmeidler
Journal:  Ann Neurol       Date:  1992-03       Impact factor: 10.422

6.  A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains.

Authors:  J R Connor; S L Menzies; S M St Martin; E J Mufson
Journal:  J Neurosci Res       Date:  1992-01       Impact factor: 4.164

7.  Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease.

Authors:  M A Smith; R K Kutty; P L Richey; S D Yan; D Stern; G J Chader; B Wiggert; R B Petersen; G Perry
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

8.  Lactotransferrin immunocytochemistry in Alzheimer and normal human brain.

Authors:  T Kawamata; I Tooyama; T Yamada; D G Walker; P L McGeer
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

9.  Chemical modification of glucosamine-6-phosphate synthase by diethyl pyrocarbonate: evidence of histidine requirement for enzymatic activity.

Authors:  M A Badet-Denisot; B Badet
Journal:  Arch Biochem Biophys       Date:  1992-02-01       Impact factor: 4.013

10.  ["Diaminobenzidine black" as a new histochemical demonstration of exogenous iron (author's transl)].

Authors:  J Nguyen-Legros; J Bizot; M Bolesse; J P Pulicani
Journal:  Histochemistry       Date:  1980
View more
  324 in total

1.  Contrasting, species-dependent modulation of copper-mediated neurotoxicity by the Alzheimer's disease amyloid precursor protein.

Authors:  Anthony R White; Gerd Multhaup; Denise Galatis; William J McKinstry; Michael W Parker; Rüdiger Pipkorn; Konrad Beyreuther; Colin L Masters; Roberto Cappai
Journal:  J Neurosci       Date:  2002-01-15       Impact factor: 6.167

2.  Inhibitors of catalase-amyloid interactions protect cells from beta-amyloid-induced oxidative stress and toxicity.

Authors:  Lila K Habib; Michelle T C Lee; Jerry Yang
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

3.  Toward understanding transverse relaxation in human brain through its field dependence.

Authors:  Fumiyuki Mitsumori; Hidehiro Watanabe; Nobuhiro Takaya; Michael Garwood; Edward J Auerbach; Shalom Michaeli; Silvia Mangia
Journal:  Magn Reson Med       Date:  2011-12-08       Impact factor: 4.668

4.  Deferiprone reduces amyloid-β and tau phosphorylation levels but not reactive oxygen species generation in hippocampus of rabbits fed a cholesterol-enriched diet.

Authors:  Jaya R P Prasanthi; Matthew Schrag; Bhanu Dasari; Gurdeep Marwarha; April Dickson; Wolff M Kirsch; Othman Ghribi
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

5.  Impact of endogenous nitric oxide on microglial cell energy metabolism and labile iron pool.

Authors:  Benoît Chénais; Hamid Morjani; Jean-Claude Drapier
Journal:  J Neurochem       Date:  2002-05       Impact factor: 5.372

6.  Ex vivo T2 relaxation: associations with age-related neuropathology and cognition.

Authors:  Robert J Dawe; David A Bennett; Julie A Schneider; Sue E Leurgans; Aikaterini Kotrotsou; Patricia A Boyle; Konstantinos Arfanakis
Journal:  Neurobiol Aging       Date:  2014-02-06       Impact factor: 4.673

7.  Neuroprotection against iron-induced cell death by perineuronal nets - an in vivo analysis of oxidative stress.

Authors:  Anne Suttkus; Susanne Rohn; Carsten Jäger; Thomas Arendt; Markus Morawski
Journal:  Am J Neurodegener Dis       Date:  2012-07-23

8.  Membrane-inserted conformation of transmembrane domain 4 of divalent-metal transporter.

Authors:  Hongyan Li; Fei Li; Hongzhe Sun; Zhong Ming Qian
Journal:  Biochem J       Date:  2003-06-15       Impact factor: 3.857

9.  Susceptibility MRI captures nigral pathology in patients with parkinsonian syndromes.

Authors:  Mechelle M Lewis; Guangwei Du; Jennifer Baccon; Amanda M Snyder; Ben Murie; Felicia Cooper; Christy Stetter; Lan Kong; Christopher Sica; Richard B Mailman; James R Connor; Xuemei Huang
Journal:  Mov Disord       Date:  2018-05-14       Impact factor: 10.338

Review 10.  Oxidative stress signaling in Alzheimer's disease.

Authors:  B Su; X Wang; A Nunomura; P I Moreira; H-gon Lee; G Perry; M A Smith; X Zhu
Journal:  Curr Alzheimer Res       Date:  2008-12       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.